Previous close | 0.0000 |
Open | 0.0017 |
Bid | 0.0025 x 0 |
Ask | 0.0040 x 0 |
Day's range | 0.0012 - 0.0017 |
52-week range | 0.0003 - 0.0211 |
Volume | |
Avg. volume | 25,813 |
Market cap | 4.366M |
Beta (5Y monthly) | 2.23 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0100 |
Earnings date | 29 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Elixinol Wellness Limited (ASX: EXL) continues to be a pioneer in the global hemp industry, with the release of a new paper into the safety of Elixinol Hemp Extract in leading scientific publication, Journal of Toxicology.